Loading…

Downregulation of miR-218-5p promotes invasion of oral squamous cell carcinoma cells via activation of CD44-ROCK signaling

[Display omitted] •Isolate the invasion front cells of the OSCC using microfluidic chip.•Invasion front cells show high invasive capacity and decrease of miR-218-5p.•Downregulation of miR-218-5p promotes OSCC invasion by targeting CD44–ROCK pathway. The invasion front of oral squamous cell carcinoma...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicine & pharmacotherapy 2018-10, Vol.106, p.646-654
Main Authors: Li, Xiaojie, He, Jianya, Shao, Miaomiao, Cui, Bai, Peng, Fei, Li, Jiao, Ran, Yan, Jin, Dong, Kong, Jing, Chang, Jinming, Duan, Liqiang, Yang, Xuesong, Luo, Yong, Lu, Yao, Lin, Bingcheng, Liu, Tingjiao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •Isolate the invasion front cells of the OSCC using microfluidic chip.•Invasion front cells show high invasive capacity and decrease of miR-218-5p.•Downregulation of miR-218-5p promotes OSCC invasion by targeting CD44–ROCK pathway. The invasion front of oral squamous cell carcinoma (OSCC) harbors the most aggressive cells of the tumor and is critical for cancer invasion and metastasis. MicroRNAs (miRNAs) play important roles in OSCC progression. In this study, we modelled the OSCC invasion front on a microfluidic chip, and investigated differences in miRNA profiles between cells in the invasion front and those in the tumor mass by small RNA sequencing. We found that miR-218-5p was downregulated in invasion front cells and negatively regulates OSCC invasiveness by targeting the CD44–ROCK pathway. Thus, miR-218-5p may serve as a useful therapeutic target for OSCC. Moreover, invasion front cell isolation based-on microfluidic technology provided a useful strategy for cancer invasion study.
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2018.06.151